Produktname:5-Fluoro-2-hydroxy-N,N-diisopropylbenzamide
IUPAC Name:5-fluoro-2-hydroxy-N,N-bis(propan-2-yl)benzamide
- CAS：1394933-63-1
- Molekulare Formel：C13H18FNO2
- Reinheit：95%+
- Katalognummer：CM562498
- Molekulargewicht：239.29
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1394933-63-1
- Molekulare Formel:C13H18FNO2
- Schmelzpunkt:-
- SMILES-Code:O=C(N(C(C)C)C(C)C)C1=CC(F)=CC=C1O
- Dichte:
- Katalognummer:CM562498
- Molekulargewicht:239.29
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- DSP-5336
- Sumitomo Pharma announces that DSP-5336 has received FDA Fast Track Designation for the treatment of relapsed or refractory acute myeloid leukemia (AML) with a KMT2A rearrangement, also known as, mixed lineage leukemia rearrangement (MLLr) or nucleophosmin mutation (NPM1m). Menin serves as a tumor suppressor in endocrine glands. Novel menin inhibitors are novel targeted agents in clinical studies targeting genetically defined subsets of acute leukemia.
DSP-5336 is an investigational menin-MLL interaction inhibitor. DSP-5336 has been granted Orphan Drug Designation in acute myeloid leukemia, and Fast Track Designation in relapsed or refractory acute myeloid leukemia with MLLr or NPM1m.
Suche 
+86 21 5895 0110 
